Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 528.00
Bid: 526.00
Ask: 530.00
Change: -4.00 (-0.75%)
Spread: 4.00 (0.76%)
Open: 525.00
High: 535.00
Low: 525.00
Prev. Close: 532.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Award and Director Dealings

19 Jan 2017 07:01

RNS Number : 5473U
Polar Capital Holdings PLC
19 January 2017
 

19 January 2017

Polar Capital Holdings plc

Share Award and Director Dealings

 

Further to the announcement of the prospective appointment of Mr Gavin Rochussen as CEO of Polar Capital Holdings plc ("Polar Capital" or the "Group") the Group confirms that as part of Mr Rochussen's remuneration package he will join the Company's Long Term Incentive Plan ("LTIP") and that, on appointment Mr Rochussen will be awarded a deferred interest in three million pounds value of ordinary shares ("Ordinary Shares") in the Group (the "LTIP Award"). In order to satisfy the LTIP Award it is expected that in due course a recommendation will be made to the Group's Employee Benefit Trust that it purchase these Ordinary Shares in the market.

In addition to the LTIP Award Mr Rochussen has informed the Board of his intention to purchase in the market for his own account or via a nominee, subject to the normal rules of the Group's share dealing policy, up to one million Ordinary Shares at a price of up to 300p (the "Price").

Senior executives and significant shareholders of Polar Capital, Mr Tim Woolley, Mr Brian Ashford-Russell and Mr Robert Gurner are extremely supportive of Mr Rochussen's appointment and wish to ensure that he is able to start his role with a meaningful equity interest. To this end, they have indicated that, in the event that Mr Rochussen is unable to complete his purchase at the Price in the market, they would make up any shortfall and sell Ordinary Shares at the Price.

The Board of Polar Capital is delighted with the material financial investment being made by Mr Rochussen in the capital of the Group which, together with the LTIP Award, will significantly align his interests with those of all shareholders.

Mr Rochussen will purchase his shares through the Group's Nomad and Joint Broker, Canaccord Genuity and further details of the purchase will be provided at the time.

Enquiries:

 

Polar Capital Holdings PLC

Tim Woolley (CEO)John Mansell (COO)

 

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Andrew Buchanan

Kit Stephenson

 

+44 (0)20 7523 8000

 

Peel Hunt - Joint Broker

Guy Wiehahn

 

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

+44 (0)20 3757 4984

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKFDDFBKDPDD
Date   Source Headline
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.